I 111th CONGRESS 1st Session H. R. 2458 IN THE HOUSE OF REPRESENTATIVES May 18, 2009 Mr. Lamborn (for himself, Mr. Akin, Mrs. Bachmann, Mr. Bartlett, Mrs. Blackburn, Mr. Boozman, Mr. Brady of Texas, Mr. Burton of Indiana, Mr. Calvert, Mr. Conaway, Ms. Fallin, Mr. Fleming, Mr. Franks of Arizona, Mr. Gingrey of Georgia, Mr. Gohmert, Mr. Hensarling, Mr. Hoekstra, Mr. Hunter, Mr. Sam Johnson of Texas, Mr. Jones, Mr. Jordan of Ohio, Mr. King of Iowa, Mr. Kline of Minnesota, Mr. Latta, Mr. Linder, Mr. Marchant, Mr. McClintock, Mr. McCotter, Mr. McHenry, Mr. McKeon, Mrs. McMorris Rodgers, Mr. Moran of Kansas, Mr. Neugebauer, Mr. Pence, Mr. Pitts, Mrs. Schmidt, Mr. Shimkus, Mr. Souder, Mr. Tiahrt, Mr. Wittman, and Mr. Miller of Florida) introduced the following bill; which was referred to the Committee on Education and Labor A BILL To amend the General Education Provisions Act to prohibit Federal education funding for elementary or secondary schools that provide access to emergency postcoital contraception.

1.

Short title

This Act may be cited as the Schoolchildren’s Health Protection Act.

2.

Schoolchildren’s health protection

The General Education Provisions Act (20 U.S.C. 1221 et seq.) is amended by adding at the end the following new part: E

Schoolchildren’s health protection

461.

Limitation on funding

Notwithstanding any other provision of Federal law, no funds shall be made available from any applicable program to a State educational agency or local educational agency that distributes or provides postcoital emergency contraception (such as the so-called morning-after pill) or a prescription for such contraception on the premises, or in the facilities, of an elementary school or secondary school.

462.

Definition

In this part, the term postcoital emergency contraception means— (1)any of the regimens described in the notice entitled Prescription Drug Products; Certain Combined Oral Contraceptives for Use as Postcoital Emergency Contraception, published in the Federal Register on February 25, 1997 (62 FR 8610), or any subsequent corresponding notice; or (2)any other drug or device to be used after fertilization may have occurred and for the same purposes as the regimes in subparagraph (A).

.